FindTrial
Sign In

ABT-751

DRUG11 trials

Sponsors

National Institutes of Health Clinical Center (CC), M.D. Anderson Cancer Center, Abbott, AbbVie (prior sponsor, Abbott), Children's Oncology Group

Conditions

Acute Lymphoblastic LeukemiaBrain and Central Nervous System TumorsBreast CancerChildhood Germ Cell TumorColorectal CancerDisseminated NeuroblastomaExtragonadal Germ Cell TumorHematological Malignancies

Phase 1

Study of ABT-751 in Patients With Refractory Hematologic Malignancies
CompletedNCT00047489
M.D. Anderson Cancer CenterHematological Malignancies
Start: 2002-12-31End: 2005-01-31Updated: 2018-10-31
ABT-751 in Treating Young Patients With Refractory Solid Tumors
CompletedNCT00036959
National Institutes of Health Clinical Center (CC)Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor +6
Start: 2002-03-31End: 2010-02-28Target: 90Updated: 2012-03-15
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
CompletedNCT00297089
AbbVie (prior sponsor, Abbott)Lung Cancer, Non-Small-Cell Lung Cancer, NSCLC
Start: 2006-11-30End: 2009-01-31Updated: 2013-01-31
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
TerminatedNCT00354562
AbbottLung Cancer, Non-Small Cell Lung Cancer
Start: 2007-02-28Updated: 2011-01-07
ABT-751 With Chemotherapy for Relapsed Pediatric ALL
TerminatedNCT00439296
Therapeutic Advances in Childhood Leukemia ConsortiumAcute Lymphoblastic Leukemia, Recurrent Pediatric ALL, Refractory Pediatric ALL +1
Start: 2006-05-22End: 2009-09-23Updated: 2021-03-17
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
TerminatedNCT00471718
Vanderbilt-Ingram Cancer CenterProstate Cancer
Start: 2004-01-31End: 2009-08-31Updated: 2012-07-11

Phase 2

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
CompletedNCT00063102
AbbottBreast Cancer
Start: 2002-11-30End: 2004-08-31Target: 40Updated: 2007-11-29
A Study of ABT-751 in Patients With Colorectal Cancer
CompletedNCT00073138
AbbottColorectal Cancer
Start: 2003-08-31End: 2005-02-28Target: 40Updated: 2007-11-29
A Study of ABT-751 in Patients With Renal Cell Cancer
CompletedNCT00073112
AbbottRenal Cell Cancer
Start: 2003-08-31End: 2006-09-30Target: 60Updated: 2007-11-29
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
CompletedNCT00073151
AbbottNon-Small Cell Lung Cancer
Start: 2003-09-30End: 2006-01-31Target: 30Updated: 2007-11-29
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
CompletedNCT00436852
Children's Oncology GroupDisseminated Neuroblastoma, Recurrent Neuroblastoma
Start: 2007-01-31End: 2015-03-30Updated: 2019-07-17

Related Papers

Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).
2013-12-1812 citations